Evidence map›Paper›PMID 28694334›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.

Lauren E McLane, Jennifer N Bourne, Angelina V Evangelou, Luipa Khandker, Wendy B Macklin, Teresa L Wood

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. R-Ras GTPases Signaling Role in Myelin Neurodegenerative Diseases.International journal of molecular sciences · 2020
    Review
  11. Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. mTORC1 Activation by Loss ofFrontiers in cellular neuroscience · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lauren E McLaneDepartment of Pharmacology, Physiology, and Neuroscience and Cancer Center, New Jersey Medical School, Rutgers University, Newark, New Jersey 07101, and.ORCID 0000-0003-2751-7547
Jennifer N BourneDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045.
Angelina V EvangelouDepartment of Pharmacology, Physiology, and Neuroscience and Cancer Center, New Jersey Medical School, Rutgers University, Newark, New Jersey 07101, and.ORCID 0000-0002-4946-3183
Luipa KhandkerDepartment of Pharmacology, Physiology, and Neuroscience and Cancer Center, New Jersey Medical School, Rutgers University, Newark, New Jersey 07101, and.
Wendy B MacklinDepartment of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado 80045.ORCID 0000-0002-1252-0607
Teresa L WoodDepartment of Pharmacology, Physiology, and Neuroscience and Cancer Center, New Jersey Medical School, Rutgers University, Newark, New Jersey 07101, and Terri.wood@rutgers.edu.ORCID 0000-0002-4480-660X
Rutgers, The State University of New Jersey · USUniversity of Colorado Denver · US

Funding

The role of mTOR signaling in oligodendrocyte differentiation and CNS myelinationR37NS082203 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MACKLIN, WENDY B, WOOD, TERESA L · 2017 to 2023
$6.0M
The role of mTOR signaling in oligodendrocyte differentiation and CNS myelinationR01NS082203 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MACKLIN, WENDY B, WOOD, TERESA L · 2012 to 2016
$3.3M
NINDS NIH HHS R01 NS082203NINDS NIH HHS R37 NS082203
6 · The paper itself

Abstract

Although the mammalian target of rapamycin (mTOR) is an essential regulator of developmental oligodendrocyte differentiation and myelination, oligodendrocyte-specific deletion of tuberous sclerosis complex (TSC), a major upstream inhibitor of mTOR, surprisingly also leads to hypomyelination during CNS development. However, the function of TSC has not been studied in the context of remyelination. Here, we used the inducible Cre-lox system to study the function of TSC in the remyelination of a focal, lysolecithin-demyelinated lesion in adult male mice. Using two different mouse models in which

Indexed as

AnimalsAxonsCell DifferentiationCells, CulturedDemyelinating DiseasesMaleMiceMice, Inbred C57BLMice, KnockoutMyelin SheathNerve Fibers, MyelinatedNerve RegenerationOligodendrogliaStem CellsTuberous Sclerosis Complex 1 ProteinTumor Suppressor ProteinsTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinTumor Suppressor Proteinsadult OPCsmTORNG2remyelinationTSC

Identifiers

PMID28694334
PMCPMC5546116
OpenAlexW2735630793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.